AGP Executive Report
Last update: 4 hours agoTB Research: A new 4-month TB regimen using sutezolid in a PanTB-HM phase 2c trial showed stronger lung function recovery (FEV1) than standard 6-month HRZE therapy in adults across South Africa, Tanzania and Mozambique. Child Health & Flood Response: Mozambique’s Finance Minister says UNICEF is a key partner for child health and education, including support for flood-affected provinces and a major emergency appeal for flood victims. Health Aid & Rights: Human Rights Watch warns US health agreements with several African countries—including Mozambique—are tied to “troubling conditions” like access to sensitive health data and pathogen samples. Dengue Vaccine Push: DENSTAR launched with €11.09m to speed development, testing and regulatory approval of a next-generation dengue vaccine for sub-Saharan Africa, with partners including KNUST. Mozambique Safety: Catholic bishops and Mozambique’s Church mourn Bishop Osório Citora Afonso, found shot dead at his residence in Quelimane; calls grow for a thorough investigation and better protection for pastoral workers. Migration & Health Pressure: South Africa’s Ramaphosa promises action on illegal migration amid anti-foreigner protests, while rights groups warn crackdowns can worsen strain on public health services. Repatriation at Lebombo: South Africa’s BMA reports 141 Mozambicans deported/processed via Lebombo Port, with biometric checks for criminal links. Public Health Systems: UNICEF and other partners highlight how health services and child development are being hit by shocks like floods and wider instability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.